about
In vitro model of bone to facilitate measurement of adhesion forces and super-resolution imaging of osteoclastsProtein kinase C (PKC) family in cancer progressionRestricted distribution of mRNAs encoding a sarcoplasmic reticulum or transverse tubule protein in skeletal myofibersNeurofibromatosis type 1 is not associated with subarachnoid haemorrhage.Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes.Collagen gene expression by cultured human skin fibroblasts. Abundant steady-state levels of type VI procollagen messenger RNAs.Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinomaUltraviolet radiation in skin ageing and carcinogenesis: the role of retinoids for treatment and prevention.Association of Catechol-O-methyltransferase polymorphism Val158Met and mammographic density: A meta-analysis.Hypoxic conditions stimulate the release of B-type natriuretic peptide from human retinal pigment epithelium cell culture.Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Gö6976.Connective tissue metabolism in diabetic peripheral nerves.A fibroblast cell line cultured from a hypertrophic scar displays selective downregulation of collagen gene expression: barely detectable messenger RNA levels of the pro alpha 1(III) chain of type III collagen.Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-statAltered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1.Laminin-5 expression is independent of the injury and the microenvironment during reepithelialization of wounds.Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.Fibronectin gene expression by epithelial tumor cells in basal cell carcinoma: an immunocytochemical and in situ hybridization study.Differential effects of hexoses and sucrose, and platelet-derived growth factor isoforms on cyclooxygenase-1 and -2 mRNA expression in keloid, hypertrophic scar and granulation tissue fibroblasts.Cytoskeletal structure of myoblasts with the mitochondrial DNA 3243A-->G mutation and of osteosarcoma cells with respiratory chain deficiency.Expression of extracellular matrix genes by cultured human cells: localization of messenger RNAs and antigenic epitopes.Incidence and mortality of neurofibromatosis: a total population study in Finland.Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.Collagens in neurofibromas and neurofibroma cell cultures.Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells.The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes.Prevalence of neurofibromatosis type 1 in the Finnish population.NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.High-Throughput Dual Screening Method for Ras Activities and Inhibitors.The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.Cytoskeletal structure in cells harboring two mutations: R133C in NOTCH3 and 5650G>A in mitochondrial DNA.Periapical cemental dysplasia is common in women with NF1.Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options.Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve.PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells.Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis.
P50
Q27334454-C2E23595-0B08-4D54-A106-8D5E52E97D9EQ28252013-613E2390-2EFE-4BC6-8394-50C979E9441FQ28567409-8179BC1E-252C-4589-90BD-1F0BD1CF3551Q33757823-F5533EEE-D803-4927-ABAA-35AFC7821D2DQ34200369-66F42726-7275-4188-BAB5-97D3A29C5905Q34283611-8632D32B-1DA1-4ABD-B254-F5F7F33A99EBQ34567844-4D0316D9-94B3-4C31-835E-BAB0B8C76CB8Q35168178-DC50C3C1-83B7-463A-B41B-0C92E47F2758Q36845574-60BF8198-F45C-45A1-9BDC-8B1E5235DC69Q38687617-5B72F87E-A4BA-441C-9049-055152D82490Q39003438-701F1F97-5D47-478C-A105-E015CE6576EEQ40063235-0DB84E53-0D5F-4671-A549-EB61FDAA06B0Q40744825-9D28A7CA-77C3-4809-B620-9A72258CC7ADQ41406180-8ED1E266-FA22-4CEE-9B81-3DB3B559A7D8Q41722843-1C8C82DF-39CE-4110-BACC-378EADE393C6Q42048048-DB257C11-ED9E-45DA-9D3E-19A07933734BQ42451596-7EA46DF2-088B-494C-B327-6CB3C63BB526Q42489214-D210B03E-B58E-4EF7-B938-4576A87B43BDQ42489393-07C23EDC-E373-4D76-A55E-2D8D5C0730A0Q43611101-014BC696-E499-4B97-8DB8-200FEEB05787Q44125252-AEE66B8B-E324-4F75-98AD-A170101EAE9DQ44311378-AFE67572-59A9-43BC-9D0F-537523A67EBEQ44390105-C8027B5C-E658-420F-A418-6660491A105CQ44815214-78B9547B-CFFC-4A50-BF26-A1A72638438DQ44983718-8108CACE-E71D-424D-B9AB-D22D307856BBQ45020394-50189256-7BE7-4735-826D-33EF1057692EQ45286276-EC1F4353-96E7-407A-B5C3-96FEDA13D326Q47351462-788097BD-E1F4-4F78-BDC7-35960B082D97Q47654099-477C8ED3-936A-4B3D-A7ED-DE26DA641339Q48011726-ADB1A6CB-CA03-4392-8D3D-4DADDA102FC6Q48044552-C4FB0A99-AFA7-45A1-95E7-956AF5650846Q48219696-85E1A36C-428E-4F6D-87BF-A58198A657A7Q50625815-4D7ED7F4-3218-4E71-97FE-0DCA4AD96383Q50706495-BF8B2F8D-3A76-4683-93BE-A6D35C6CD0CFQ51751977-23BB0862-48DD-4504-B5BE-2FF4AEDD6625Q51926007-01C19572-B9CB-44B7-BD96-5EC0068C2127Q52171232-ADBC73FE-FC1A-4D9F-B830-84682F3B6114Q53569412-545D0267-67D7-41F4-A813-9A3A01BB9AE3Q54309945-3081107E-4C2C-4007-B203-0F2A13F8B555Q54774599-F6F0CECB-3122-486B-9389-BC3C49211648
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juha Peltonen
@ast
Juha Peltonen
@en
Juha Peltonen
@es
Juha Peltonen
@nl
Juha Peltonen
@sl
type
label
Juha Peltonen
@ast
Juha Peltonen
@en
Juha Peltonen
@es
Juha Peltonen
@nl
Juha Peltonen
@sl
prefLabel
Juha Peltonen
@ast
Juha Peltonen
@en
Juha Peltonen
@es
Juha Peltonen
@nl
Juha Peltonen
@sl
P1053
C-2817-2008
P106
P21
P31
P3829
P496
0000-0002-5732-4167